HEMERION
LIVE

Serial Number

90554690

Owner

HEMERION THERAPEUTICS

Attorney

Pina Campagna

First Use Date

Oct 1, 2023

Filing Date

Mar 2, 2021

Add to watchlist:

No watchlists yet
View on USPTO

HEMERION Trademark

Serial Number: 90554690 • Registration: 7697787

HEMERION is a trademark filed by HEMERION THERAPEUTICS on March 2, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

HEMERION THERAPEUTICS (4 trademarks)

Villeneuve-d'Ascq 59650 , FR

Entity Type: 99

Trademark Details

Filing Date

March 2, 2021

Registration Date

February 18, 2025

First Use Anywhere

October 1, 2023

First Use in Commerce

April 11, 2024

Published for Opposition

November 30, 2021

Goods & Services

Pharmaceutical products for the prevention and treatment of cancer; pharmaceutical, medical and veterinary preparations for the prevention and treatment of cancer; Sanitary preparations for medical purposes; Pharmaceutical preparations for the diagnosis and treatment of oncological and inflammatory diseases and disorders; Medicinal preparations for the treatment of infectious diseases and for use in oncology

(Based on 44(e)) Surgical and medical apparatus and instruments, namely, surgical instruments and apparatus, medical devices for detecting and treating cancer, x-ray apparatus and surgical apparatus and instruments for medical use; Medical imaging apparatus; Medical instruments for diagnosis and treatment of cancer; Lasers for surgical and medical use; Medical apparatus for the treatment of cancerous tumors; Radiological apparatus for medical purposes; Medical imaging apparatus for use in the field of oncology for diagnostic purposes; Radiotherapy apparatus; Medical diagnostic apparatus for detecting or testing cancer; Implantable subcutaneous drug delivery apparatus, specifically, implantable drug delivery ports and implantable drug delivery pumps; fluid injectors for medical purposes; probes for medical purposes

(Based on 44(e)) Scientific research for medical and surgical purposes in the field of cancerous diseases; Pharmaceutical research and development; Scientific and medical research in the field of lasers; Scientific research for medical and surgical purposes in the field of oncology, specifically, cancerous diseases; Conducting clinical trials as pharmaceutical research for others in the pharmaceutical field; Conduction preclinical trials as pharmaceutical research for others in the pharmaceutical field; in-vitro testing services, specifically, in vitro pharmaceutical testing being pharmaceutical research in the pharmaceutical field; scientific studies and research for medical and surgical purposes in the field of oncology, specifically, cancerous diseases; medical, pharmacological, biological and chemical studies and research all being scientific research for surgical and medical purposes in the field of cancerous diseases; pharmaceutical research and development of new medical devices and pharmaceutical products; pharmaceutical research services, namely, performance of biological, chemical and pharmacological analyses of pharmaceutical products

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 18, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 28, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 28, 2025 CNPR
ASSIGNED TO EXAMINER
Jan 13, 2025 DOCK
STATEMENT OF USE PROCESSING COMPLETE
Sep 11, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 11, 2024 AITU
USE AMENDMENT FILED
Jul 10, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 10, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 23, 2024 EXRA
SOU EXTENSION 4 GRANTED
Jan 19, 2024 EX4G
SOU EXTENSION 4 FILED
Jan 19, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 19, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 22, 2023 EXRA
SOU EXTENSION 3 GRANTED
Jul 20, 2023 EX3G
SOU EXTENSION 3 FILED
Jul 20, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 20, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 13, 2023 EXRA
SOU EXTENSION 2 GRANTED
Jan 11, 2023 EX2G
SOU EXTENSION 2 FILED
Jan 11, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 11, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 29, 2022 EXRA
SOU EXTENSION 1 GRANTED
Jun 27, 2022 EX1G
SOU EXTENSION 1 FILED
Jun 27, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 27, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 25, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 30, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 30, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 10, 2021 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Oct 28, 2021 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Oct 22, 2021 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 21, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 21, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 21, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 21, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 21, 2021 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 28, 2021 GNRN
NON-FINAL ACTION E-MAILED
Sep 28, 2021 GNRT
NON-FINAL ACTION WRITTEN
Sep 28, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 22, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 1, 2021 NWOS
NEW APPLICATION ENTERED
Mar 5, 2021 NWAP